Abstract 16 Antimicrobial resistance (AMR) threats are typically represented by bacteria capable of 17 extensive horizontal gene transfer (HGT). One clear exception is Mycobacterium tuberculosis 18 (Mtb). It is an obligate human pathogen with limited genetic diversity and a low mutation rate 19 which further lacks any evidence for HGT. Such features should in principle reduce its ability to 20 rapidly evolve AMR. We identify key features in its biology and epidemiology that allows it to 21 overcome its low adaptive potential. We focus in particular on its innate resistance to drugs, 22 unusual life cycle including an often extensive latent phase and its ability to shelter from 23 exposure to antimicrobial drugs within cavities it induces in the lungs. 24 So Special 25 The rapid increase of antimicrobial resistance (AMR; see Glossary) in bacteria is driven by the 26 widespread use, abuse and misuse of antibiotics, and constitutes one of the most challenging 27 healthcare problems globally. With the notable exception of Mycobacterium tuberculosis (Mtb) 28 the agent of tuberculosis (TB), all other bacterial species listed as current AMR threats by the 29 Centers for Disease Control http://www.cdc.gov/drugresistance/biggest_threats.htmltrend 30 frequently exchange genetic material and frequently acquire novel mutations through gain of 31 new genes by horizontal gene transfer (HGT) rather than de novo mutations ( Figure 1) . Mtb has 32 a virtually non-existent accessory genome, meaning that almost all genes are common to all 33 strains. Evidence suggests that there is little or no recombination occurring in the species. In 34 addition to its strictly clonal reproduction, Mtb is characterized by a low mutation rate and 35 limited genetic diversity, which has led to it being considered as a 'monomorphic bacterium' 36 [1] . Mtb also stands out from most other bacteria considered as AMR threats by being an 37 obligate pathogen. 38 The lack of HGT combined with a low mutation rate makes Mtb an a priori unlikely foe 39 outwitting considerable efforts aiming at defeating it. Yet, multi-drug resistant TB resistant to isoniazid (INH) and rifampicin (RIF)] and extensively-drug resistant TB (XDR-TB; 41 MDR-TB with additional resistance to second-line injectable drugs and fluoroquinolones) 42 represent a significant and growing threat to global health accounting for nearly half a million 43 new cases and around 200,000 deaths in 2014 alone 44 http://www.who.int/tb/publications/global_report/en/. Resistance has also been shown to 45 emerge essentially immediately after the introduction of new drugs and highly resistant strains 46 of Mtb have been in circulation for at least four decades [2, 3] . In this review we explore why 47 Mtb is such a severe public health problem despite being an outlier amongst other AMR 48 threats. To search for clues, we review the key features of its biology, life history and 49 epidemiology in the wider phylogenetic context of the bewildering diversity of mycobacteria. 50 We conclude that compared to other bacterial resistance threats, the strict reliance of Mtb on 51 de novo chromosomal mutations has led to a relatively slow rate of emergence of AMR. 52 However, the proportion of resistant strains is increasing and this trend is proving difficult to 53 contain due to various public health failings, the intrinsic resistance of mycobacteria to a range 54 of antibiotics and life-style properties such as the ability of Mtb to hide in pulmonary cavities 55 and lesions with limited drug penetrance.
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The genus Mycobacterium contains well over 100 recognized species and probably an equally 58 large number of species yet to be discovered. The genetic diversity within described species 59 varies significantly, and this discrepancy follows a simple rule: the more attention a group of 60 mycobacteria has received, the more likely it has been split into multiple species. The genus 61 mainly comprises environmental bacteria, but a number of these can cause opportunistic 62 infections in humans ( Figure 2 ). The more host-specialized members exhibit a clonal mode of 63 inheritance, but recombination is frequent in the genus as a whole. 64 A comparative analysis including 13 mycobacterial species found only sporadic evidence of 65 recombination in core genes within Mycobacteria, but genome content analyses suggest that 66 horizontal acquisition of genes is frequent and played an important role in the evolution of this 67 group [4] . The presence of numerous genomic islands dispersed across different mycobacterial 68 species is also suggestive of extensive horizontal gene transfer from outside the genus [ 76 Mycobacteria are intrinsically resistant to a number of antimicrobial compounds, an 77 observation that is often explained by the presence of an impermeable mycolic acid-rich cell 78 envelope. In addition, mycobacteria are members of the order Actinomycetales which also 79 includes Streptomyces species, well known for their ability to produce a wide range of 80 antibiotics. Antibiotic-producing bacteria must have defence mechanisms in place to guard 81 them against their own toxic compounds. The inducible whiB7 multidrug-resistance system 82 common to all Actinomycetales has been shown to reduce susceptibility to a wide range of 83 antimicrobials, including macrolides, chloramphenicol, tetracycline and aminoglycosides [8] . In 84 Mtb, the regulon includes genes involved in drug efflux (tap), a putative macrolide exporter 85 (Rv1473), the ribosomal methyltransferase erm and the aminoglycoside acetyltransferase eis 86 [8].
87
Mtb and closely related animal strains, together with the leprosy bacilli are unusual insofar they 88 constitute specialized pathogens of humans and other mammals ( Figure 2) . In contrast to most 89 other mycobacteria, these bacilli readily transmit between mammalian hosts, a hallmark of true 90 pathogens [9] . Despite the general perception that leprosy is a disease of the past, nearly a 91 quarter million cases are reported yearly [10] . The ruminant-infecting Mycobacterium avium 92 subsp. paratuberculosis also deserves to be mentioned as a host-specialized pathogen. 93 However, even though this subspecies can only grow intracellularly, it can survive for long 94 periods in the environment and transmits via the faecal-oral route and possibly also via 95 nematodes and protozoa [11] . 96 97 Genome-level comparison of Mtb and M. marinum revealed that Mtb has also undergone a 98 process of genome downsizing on its path from an environmental ancestor to a specialized 99 mainly intracellular pathogen [12], but on a far more moderate scale than the leprosy bacilli. 100 The general downsizing has however also been accompanied by the acquisition of a number of 101 genes, including genes involved in virulence [12] . There is strong evidence that recombination medication is available to most, but the health system infrastructure is often weak and 222 antimicrobial stewardship is lacking [46] . Another possible explanation for the regional 223 differences in resistance burden could be due to phenotypic differences between strains. If the 224 dominant lineage in a region were more prone to develop resistance than other lineages, this 225 could exacerbate the resistance burden in the region. and an earlier similar study with slightly larger sample size did not point to a higher rate of 231 acquisition of mutations of Lineage 2 strains [49] . It is possible that the Beijing lineage simply 232 happened to be at the right place at the right time with the collapse of the Soviet Union, 233 leading to the emergence of resistant strains still circulating in large numbers today. The The first clinical stage of TB infection is termed primary TB and typically involves the production 245 and spread of granulomas systemically and to regional lymph nodes [50] . Within a few weeks, 246 immunity develops and the infection regresses, but is not sterilized [50] .TB is generally more 247 virulent in animals than in humans, and common animal models such as mice, guinea pigs, The emergence of drug resistant TB is most often attributed to poor patient adherence to drug 273 treatment schemes, a problem that is ameliorated by directly observed treatment (DOT). 274 Patients are typically enrolled on anti-TB therapy for 6 to 24 months, depending on response Mtb has a low mutation rate and limited genetic diversity, lacks any mechanism for extensive 320 HGT and does not benefit from any hiding place outside its human host, such as an 321 environmental or zoonotic reservoir. It remains to be defined what exact form a determined 322 assault against AMR-TB (and TB more generally) should take. However, it is clear that any 323 successful public health strategy will have to be informed by robust fundamental scientific 324 evidence and be multipronged to be successful. We have learned a lot about Mtb and TB, in 325 particular since the advent of fast and affordable sequencing technologies. However, it would 326 be foolish to assume that the current knowledge is sufficient to vanquish Mtb (see Outstanding 327 Questions), as it remains a deadly and surprisingly adaptable foe despite its apparent inherent 328 weaknesses. antimicrobials is challenging, as the group is intrinsically resistant to most available drugs [84] . 583 The species harbors three subspecies, namely abscessus, bolettii and masilliense. The macrolide 584 clarithromycin has been used frequently to treat infections, but the relatively recent discovery 585 that nearly all abscessus and bolettii strains, but not masilliense, can induce resistance to the 586 drug by activation of the erm(41) gene [85], encoding a ribosome methylase [86] , highlights 587 critical differences within this species complex and the need for improved taxonomic 588 assignment tools for effective treatment. seems to have been partially driven by the expansion of insertion sequence IS2404 that was 604 acquired after the split between M. marinum and M. ulcerans. Insertion sequences seem to 605 have played important roles also in the host-adaption of other pathogenic mycobacteria. M. 606 ulcerans has been identified in a wide range of environments, including soil, water, frogs, fish, 607 mosquitos, water bugs and mammals. However, the finding that mycolactone specifically 608 inhibits T-cell controlling mammalian microRNAs [89] combined with a very close genetic 609 relationship between M. ulcerans isolates in humans and opossums in southwest Australia [90] 610 do suggest that the bacterium has evolved to accommodate a mammalian niche. 611 612 Box 2 Terrible Places (for MDR-TB) 613 In India, 4.3 % of notified TB cases were estimated to be MDR-TB in 2013, but within the 614 country there are significant regional differences in resistance burden. A survey of four Results from first-line diagnostics reported annually in South Africa found 6.6 % of all TB cases 620 in South Africa to be RIF resistant in 2013/2014 [83] . However, in the province of KwaZulu-Natal 621 which is home to 30% of all TB cases in the country, and the region with the highest incidence 622 of MDR-TB in the world, 8.9% of TB cases were RIF resistant in the same period. RIF-resistance 623 is often used as a proxy for MDR, an assumption that is correct in more than 90% of the cases in country-wide study one year later that confirmed that 45.5% of all isolates in Belarus are 629 indeed MDR-TB. Possibly, even more shocking was the observation that among MDR-TB 630 isolates, 11.9% were XDR [80] . 631 632
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